BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Diagnosis
133 results:

  • 1. Impact of
    Narlı Özdemir Z; İpek Y; Patır P; Ermiş G; Çiftçiler R; Özmen D; Baysal M; Gürsoy V; Yıldızhan E; Güven S; Ercan T; Elibol T; Mersin S; Genç E; Davulcu EA; Karakuş V; Erkut N; Güneş G; Diz Küçükkaya R; Eşkazan AE
    Turk J Haematol; 2024 Mar; 41(1):26-36. PubMed ID: 38433449
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study.
    England JT; Szuber N; Sirhan S; Dunne T; Cerquozzi S; Hill M; Villeneuve PJA; Ho JM; Sadikovic B; Bhai P; Krishnan N; Dowhanik S; Hillis C; Capo-Chichi JM; Tsui H; Cheung V; Gauthier K; Sibai H; Davidson MB; Bankar A; Kotchetkov R; Gupta V; Maze D
    Leukemia; 2024 Mar; 38(3):570-578. PubMed ID: 38321107
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.
    Tefferi A; Vannucchi AM; Barbui T
    Am J Hematol; 2024 Apr; 99(4):697-718. PubMed ID: 38269572
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Clonal hematopoiesis and its evolution of myeloproliferative neoplasms].
    Zhang L; Dong H
    Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(45):3608-3614. PubMed ID: 38018059
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Extreme thrombocytosis with an aggressive evolution harboring a novel variant of calreticulin (calr) in exon 3.
    Bonnet S; Carillo S; Legrand B; Burroni B; Lavabre-Bertrand T; Requirand G; Robert N; Fornero L; Al Mansoori A; Moreaux J; Cartron G; Gabellier L; Herbaux C
    Eur J Haematol; 2024 Mar; 112(3):475-478. PubMed ID: 37918825
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Role of Flow Cytometry in the diagnosis of Chronic Myeloid leukemia].
    Huang W; Liu RR; Wu YY; Li SS; Tang YM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1327-1332. PubMed ID: 37846680
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The feasibility of implementing Toronto childhood cancer stage guidelines and estimating the impact on outcome for childhood cancers in seven pediatric oncology units in sub-Saharan Africa. A study from the Franco-African Pediatric Oncology Group.
    Mallon B; Kaboré R; Couitchere L; Akonde FB; Narison MLR; Budiongo A; Dackono TA; Pondy A; Diedhiou F; Patte C; Steliarova-Foucher E; Clavel J
    Pediatr Blood Cancer; 2023 Dec; 70(12):e30664. PubMed ID: 37732944
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Enhancing information on stage at diagnosis for childhood cancer in Africa.
    Liu B; Abraham N; Chitsike I; Sylvie CGL; Kambugu J; Stévy NMA; Pondy AHO; Renner L; Parkin DM
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30555. PubMed ID: 37432023
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Breastfeeding and risk of childhood brain tumors: a report from the Childhood Cancer and leukemia International Consortium.
    Schraw JM; Petridou ET; Bonaventure A; Dockerty JD; Karalexi M; Ntzani E; Infante-Rivard C; Clavel J; Bracci PM; McKean-Cowdin R; Roman E; Kane E; Erdmann F; Schüz J; Mueller BA; Scheurer ME
    Cancer Causes Control; 2023 Nov; 34(11):1005-1015. PubMed ID: 37421504
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Clinical characteristics and prognostic factors of patients with Philadelphia-negative myeloproliferative neoplasm accelerated/blast phase].
    Yan X; Qin TJ; Li B; Qu SQ; Pan LJ; Li FH; Liu NN; Xiao ZJ; Xu ZF
    Zhonghua Xue Ye Xue Za Zhi; 2023 Apr; 44(4):276-283. PubMed ID: 37356995
    [No Abstract]    [Full Text] [Related]  

  • 11. Advances in molecular evaluation of myeloproliferative neoplasms.
    Li N; Chen M; Yin CC
    Semin Diagn Pathol; 2023 May; 40(3):187-194. PubMed ID: 37087305
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. JAK2/STAT5 Pathway Mutation Frequencies in South African BCR/ABL Negative MPN Patients.
    Shires KL; Rust AJ; Harryparsad R; Coburn JA; Gopie RE
    Hematol Oncol Stem Cell Ther; 2023 Apr; 16(3):291-302. PubMed ID: 37023224
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cytological diagnosis of Classic Myeloproliferative Neoplasms at the Age of Molecular Biology.
    Combaluzier S; Quessada J; Abbou N; Arcani R; Tichadou A; Gabert J; Costello R; Loosveld M; Venton G; Berda-Haddad Y
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980287
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Expression of GPNMB in renal eosinophilic tumors and its value in differential diagnosis].
    Wang Y; Hou MY; Fu Y; Meng K; Wu HY; Chen J; Xu YM; Shi J; Fan XS
    Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):358-363. PubMed ID: 36973196
    [No Abstract]    [Full Text] [Related]  

  • 15. Impact of molecular profiling on the management of patients with myelofibrosis.
    Pastor-Galán I; Martín I; Ferrer B; Hernández-Boluda JC
    Cancer Treat Rev; 2022 Sep; 109():102435. PubMed ID: 35839532
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Secondary chronic myeloid leukemia in a patient with calr and ASXL1-mutated primary myelofibrosis.
    Sobieralski P; Bieniaszewska M; Leszczyńska A; Żuk M; Wasąg B; Zaucha JM
    Int J Hematol; 2022 Sep; 116(3):442-445. PubMed ID: 35429330
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Differences in the diagnosis and treatment of hematologic malignancies attributable to health insurance coverage.
    Song EY; Shin S; Park H; Kim N; Yoon JH; Roh EY
    Medicine (Baltimore); 2022 Mar; 101(9):e29020. PubMed ID: 35244084
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Palliative Care Services within a Pediatric Hematology-Oncology Program in a Low-Resource Setting.
    Silverstein A; Butia M; Bank R; Manda G; Nyasulu C; Mwango N; Makuti S; Chikasema M; Torrey S; Hesselgrave J; Casas J; Thambo L; Msekandiana A; Chiume M; Ozuah N; Huibers MH
    J Pain Symptom Manage; 2022 May; 63(5):e473-e480. PubMed ID: 35031502
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study.
    Hashimoto Y; Ito T; Gotoh A; Nakamae M; Kimura F; Koike M; Kirito K; Wada H; Usuki K; Tanaka T; Mori T; Wakita S; Saito TI; Kada A; Saito AM; Shimoda K; Sugimoto Y; Kurokawa T; Tomita A; Edahiro Y; Akashi K; Matsumura I; Takenaka K; Komatsu N
    Int J Hematol; 2022 Feb; 115(2):208-221. PubMed ID: 34727329
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Clinical characteristics and prognosis of
    Zhang MX; Shi WZ; Liu JX; Wang CJ; Li Y; Wang W; Jiang B
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 53(5):915-920. PubMed ID: 34650294
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.